Abstract
Clinically severe, acute polyarthritis, associated with high doses of oral moxifloxacin, has been documented for the first time in a 12-y-old child. MR studies revealed massive joint effusion, as well as moderate ligament and cartilage damage. On follow-up, neither long-term sequelae nor functional impairment of the involved joints was observed.
MeSH terms
-
Anti-Bacterial Agents / adverse effects*
-
Anti-Bacterial Agents / therapeutic use*
-
Arthritis / chemically induced*
-
Arthritis / pathology
-
Aza Compounds / adverse effects*
-
Aza Compounds / therapeutic use*
-
Child
-
Fluoroquinolones
-
Humans
-
Male
-
Moxifloxacin
-
Quinolines / adverse effects*
-
Quinolines / therapeutic use*
Substances
-
Anti-Bacterial Agents
-
Aza Compounds
-
Fluoroquinolones
-
Quinolines
-
Moxifloxacin